Back to
WELLINGTON MANAGEMENT GROUP LLP
CORT
Showing 5 of 17 quarters
Position history for
WELLINGTON MANAGEMENT GROUP LLP's holdings in Corcept Therapeutics Incorporated.
No. Wellington Management Group exited its CORT (Corcept Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 33,534 shares worth $2.5M. Wellington Management Group first reported CORT in Q4 2019 and held it in 13 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.9M
Total Shares Change
-41,066
Quarter-by-Quarter History